8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study
Savino Sciascia(Ospedale San Giovanni Bosco), Simone Baldovino(Azienda Ospedaliero Universitaria San Giovanni Battista), Leticia Ceberio(Hospital Txagorritxu), A Vaccarino(Istituto di Ematologia di Bologna), Domenico Cosseddu(A. O. Ordine Mauriziano di Torino), Elisa Menegatti(Azienda Ospedaliero Universitaria San Giovanni Battista), Debora Di Simone(Ospedale San Giovanni Bosco), Stefania Stella(University of Catania), Daniela Rossi(University of Siena), Maria Tiziana Bertero(University of Turin), Dario Roccatello(5T Torino (Italy)), Mario Bazzan(Ospedale San Giovanni Bosco), Cesar Garcia-Fernandez(Complejo Hospitalario Universitario de Santiago)
Cited by 33
Related Papers
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
|New England Journal of Medicine|2001|599
GAPSS: the Global Anti-Phospholipid Syndrome Score
|Lara D. Veeken|2013|310
Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients
|Journal of Clinical Oncology|2005|305
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
|Arthritis & Rheumatology|2021|165
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients
|Internal and Emergency Medicine|2008|126